Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
fesoterodine (toviaz) (1 trial)
imidafenacin (2 trials)
Key: Kyorin Pharma (0) Acquired (2)
krp-104 (2 trials)
sitagliptin (januvia) (1 trial)
itraconazole (sporanox) (1 trial)
krp-a218 (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Urinary Bladder, Overactive (Phase 4)
Trials (5 total)
Trial APIs (6 total)